939
Participants
Start Date
September 5, 2024
Primary Completion Date
September 30, 2027
Study Completion Date
September 30, 2027
Acetazolamide
1\. 500 mg IV bolus of acetazolamide at randomization (day 0) and repeated the next 3 mornings (day 1, day 2 and day 3). This arm will also receive a placebo- Metolazone tablet together with each acetazolamide-injection.
Metolazone 2.5 MG
2\. 2.5 mg oral Metolazone at randomization (day 0) and repeated the next 3 mornings (day 1, day 2 and day 3). This arm will also receive a placebo- acetazolamide injection together with each metolazone-tablet.
Double-placebo
This arm will also receive both a placebo-acetazolamide injection together with a placebo-metolazone-tablet at randomization and repeated the next 3 mornings (day 1, day 2 and day 3).
NOT_YET_RECRUITING
Bispebjerg Hospital, Copenhagen
RECRUITING
Amager-Hvidovre Hospital, Hvidovre
RECRUITING
Herlev-Gentofte hospital, Copenhagen
Johannes Grand
OTHER